These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 36163033)

  • 1. A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma.
    Li Z; Xia Z; Yu Y; Cai L; Jian W; Wang T; Xue W; Wang X; Wang B; Zhang P; Yao W; Zhang C; Wang C
    BMC Med Genomics; 2022 Sep; 15(1):204. PubMed ID: 36163033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma.
    Zhong M; Wang X; Zhu E; Gong L; Fei L; Zhao L; Wu K; Tang C; Zhang L; Wang Z; Zheng Z
    Front Genet; 2022; 13():905051. PubMed ID: 35846134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
    Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J
    Front Immunol; 2022; 13():1021935. PubMed ID: 36248876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
    Hong Y; Lin M; Ou D; Huang Z; Shen P
    BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Expression and Prognostic Value of Co-stimulatory Molecules in Clear Cell Renal Cell Carcinoma (CcRcc).
    Wu C; Cai X; He C
    Comb Chem High Throughput Screen; 2024; 27(2):335-345. PubMed ID: 37171001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of HDAC10 as a candidate oncogene in clear cell renal carcinoma that facilitates tumor proliferation and metastasis.
    Yang L; Wei Q; Chen X; Yang Y; Huang Q; Wang B; Ma X
    Diagn Pathol; 2024 Sep; 19(1):120. PubMed ID: 39237939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
    Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
    Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
    Pan XQ; Huang W; Jin LW; Lin HZ; Xu XY
    Dis Markers; 2022; 2022():8093837. PubMed ID: 35308143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel model of pyroptosis-related molecular signatures for prognosis prediction of clear cell renal cell carcinoma patients.
    Chen J; Jiang R; Guan W; Cao Q; Tian Y; Dong K; Pan X; Cui X
    Int J Med Sci; 2024; 21(3):496-507. PubMed ID: 38250606
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma.
    Lu Q; Xi P; Xu S; Zhang Z; Gong B; Liu J; Zhu Q; Sun T; Zhu S; Chen R
    Aging (Albany NY); 2024 Mar; 16(7):6118-6134. PubMed ID: 38546385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs.
    Yu Z; Lu C; Lu B; Gao H; Liang R; Xiang W
    BMC Genomics; 2023 Mar; 24(1):162. PubMed ID: 36991314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma.
    Li T; Liu H; Dong C; Lyu J
    Front Pharmacol; 2022; 13():806995. PubMed ID: 35153782
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
    Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
    J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.
    Zhang J; Wang Y; Ma J; Aimudula A
    Front Oncol; 2023; 13():1163714. PubMed ID: 37483501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer.
    Ye Y; Dai Q; Qi H
    Cell Death Discov; 2021 Apr; 7(1):71. PubMed ID: 33828074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyroptosis-Related Gene Signature Predicts the Prognosis of ccRCC Using TCGA and Single-Cell RNA Seq Database.
    Gan Y; Zhang Z; Wang X; Li A; Fan Y; Zhang Q
    J Healthc Eng; 2022; 2022():8224618. PubMed ID: 36349258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
    Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
    Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.